StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > WHAT REALLY IS GOING ON HERE.

<< Previous

Bullboard Posts

Next >>

Comment by Directvoiceon Jun 19, 2023 5:29pm

85 Views

Post# 35504094

RE:RE:RE:RE:RE:WHAT REALLY IS GOING ON HERE.

You said you wouldn't by the test and that is normal because a marketing study shows that the maximum price a potential buyer of s cancers test was 85$.

That means that until the test is reimbursed by assurance because it has shows effectiveness, the market will be small. That said, the idea of convincing the Ontario fire department to use it to avoid treatment for future cancer make sense.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China